DIAGNOSTIKA I TERAPIYa FUNKTsIONAL'NYKh RASSTROYSTV BILIARNOGO TRAKTA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article considers the issues related to functional disorders of the biliary tract, the mechanisms of their development, clinical manifestation, diagnosis and treatment. Authors focus on modern drug therapy, and the role of spasmolytics in all major aspects of their application in this pathology. The mechanisms of action of spasmolytics, benefits, indications and conditions of use of the main groups of these drugs are described in detail. The advantage of selective myotropic spasmolytics as drugs of choice for the long-term pathogenetic treatment of digestive diseases is demonstrated.

Full Text

Restricted Access

References

  1. Kalloo AN, Pasricha PJ. Therapy of sphincter of Oddi dysfunction. Gastrointest Endosc Clin N Am 1996;6:117.
  2. Behar J, Corazziari E, Guelrud M, et al. Functional gallbladder and sphincter of Oddi disorders. Gastroenterology 2006;130:1498.
  3. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-90.
  4. Ильченко А.А. Заболевания желчного пузыря и желчных путей. Руководство для врачей. М., 2006. 448 с.
  5. Sgouros SN, Pereira SP. Systematic review: sphincter of Oddi dysfunction - non-invasive diagnostic methods and long-term outcome after endoscopic sphincterotomy. Aliment Pharmacol Ther 2006;24:237.
  6. Steinberg WM. Sphincter of Oddi dysfunction: a clinical controversy.Gastroenterology 1988;95:1409.
  7. Black NA, Thompson E, Sanderson CF. Symptoms and health status before and six weeks after open cholecystectomy: a European cohort study. ECHSS Group. European Collaborative Health Services Study Group. Gut 1994; 35:1301.
  8. Hogan WJ, Geenen JE. Biliary dyskinesia. Endoscopy 1988;20 (Suppl. 1):179.
  9. Eversman D, Fogel EL, Rusche M, et al. Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. Gastrointest Endosc 1999;50:637.
  10. Geenen JE, Hogan WJ, Dodds WJ, et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincterof-Oddi dysfunction. N Engl J Med 1989;320:82.
  11. Warshaw AL, Simeone J, Schapiro RH, et al. Objective evaluation of ampullary stenosis with ultrasonography and pancreatic stimulation. Am J Surg 1985;149:65.
  12. Darweesh RM, Dodds WJ, Hogan WJ, et al. Efficacy of quantitative hepatobiliary scintigraphy and fatty-meal sonography for evaluating patients with suspected partial common duct obstruction.Gastroenterology 1988;94:779.
  13. Simeone JF, Mueller PR, Ferrucci JT, Jr, et al. Sonography of the bile ducts after a fatty meal: an aid in detection of obstruction.Radiology 1982;143:211.
  14. Madura JA, McCammon RL, Paris JM, et al. The Nardi test and biliary manometry in the diagnosis of pancreaticobiliary sphincter dysfunction. Surgery 1981;90:588.
  15. Toouli J, Bushell M, Iannos J, et al. Peroperative sphincter of Oddi manometry: motility disorder in patients with cholelithiasis. Aust N ZJ Surg 1986;56:625.
  16. Pereira SP, Gillams A, Sgouros SN, et al. Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. Gut 2007;56:809.
  17. Sherman S, Lehman GA. Sphincter of Oddi dysfunction: diagnosis and treatment. J Pancreas 2001;2:382.
  18. Brandstatter G, Schinzel S, Wurzer H. Influence of spasmolytic analgesics on motility of sphin cter of Oddi. Dig Dis Sci 1996;41:1814.
  19. Bar-Meir S, Halpern Z, Bardan E. Nitrate therapy in a patient with papillary dysfunction. Am J Gastroenterol 1983;78:94.
  20. Guelrud M, Mendoza S, Rossiter G, et al. Effect of nifedipine on sphincter of Oddi motor activity: studies in healthy volunteers and patients with biliary dyskinesia. Gastroenterology 1988;95:1050.
  21. Sand J, Arvola P, Nordback I. Calcium channel antagonists and inhibition of human sphincter of Oddi contractions. Scand J Gastroenterol 2005;40:1394.
  22. Craig AG, Toouli J. Slow release nifedipine for patients with sphincter of Oddi dyskinesia: results of a pilot study. Intern Med J 2002;32:119.
  23. Ильченко А.А., Селезнева Э.Я. Мебеверин в купировании болей при желчнокаменной болезни. Экспериментальная и клиническая гастроэнтерология. 2002. №3. С. 57-8.
  24. Ильченко А.А., Быстровская Е.В. Опыт применения Дюспаталина при функциональных нарушениях сфинктера Одди у больных, перенесших холецистэктомию. Экспериментальная и клиническая гастроэнтерология, 2002. № 4. С. 21-2.
  25. Бутов М.А. и др. К вопросу фармакотерапии дисфункции билиарного тракта / Тезисы V съезда НОГР. 2005. C. 330-2.
  26. Лоранская И.Д., Кабанова И.Н., Вишневская В.В. и др. Применение дюспаталина у больных с патологией билиарного тракта // Эксперим. и клин. гастроэнтер. 2004. № 1. С. 60.
  27. Шелухина С.И., Бутов М.А., Лаврушин А.А. и др. Оценка клинической эффективности препарата дюспаталин и его влияние на качество жизни пациентов // Эксперим. и клин. гастроэнтер. 2004. № 1. С. 69.
  28. Moody FG, Becker JM, Potts JR. Transduodenal sphincteroplasty and transampullary septectomy for postcholecystectomy pain. Ann Surg 1983;197:627.
  29. Nardi GL, Michelassi F, Zannini P. Transduodenal sphincteroplasty. 5-25 year follow-up of 89 patients. Ann Surg 1983;198:453.
  30. Anderson TM, Pitt HA, Longmire WP, Jr. Experience with sphincteroplasty and sphincterotomy in pancreatobiliary surgery. Ann Surg 1985;201:399.
  31. Wehrmann T, Seifert H, Seipp M, et al. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 1998;30:702.
  32. Gorelick A, Barnett J, Chey W, et al. Botulinum toxin injection after biliary sphincterotomy. Endoscopy 2004;36:170.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies